NCT06012422

Brief Summary

In this study, it is aimed to evaluate parameters such as sarcopenia screening, muscle mass measurement, loss of strength that may develop due to sarcopenia, loss of balance and related fall, decrease in functionality, fragility and decreased physical activity in individuals aged 65 years and older in Kırıkkale city center.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
843

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 25, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

August 25, 2023

Status Verified

August 1, 2023

Enrollment Period

1 month

First QC Date

August 20, 2023

Last Update Submit

August 24, 2023

Conditions

Keywords

rehabilitationphysical inactivityfragility

Outcome Measures

Primary Outcomes (1)

  • Bioimpedance Analysis

    used to measure muscle mass in epidemiological studies.A muscle mass index of less than 5.5 in women and less than 7 in men is associated with the risk of sarcopenia.

    day 1

Secondary Outcomes (8)

  • Muscle Strength Evaluation

    day 1

  • Short Physical Performance Test

    day 1

  • SARC-F

    day 1

  • Mini Nutritional Assessment

    day 1

  • Physical Activity Scale for the Elderly

    day 1

  • +3 more secondary outcomes

Study Arms (1)

Individuals aged 65 and over who were screened for sarcopenia

OTHER

Persons aged 65 and over will be evaluated only once and the assessment will be made through a face-to-face interview.

Other: evaluation group

Interventions

Elderly individuals will be evaluated once, by face-to-face interview method.

Individuals aged 65 and over who were screened for sarcopenia

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Individuals aged 65 and over
  • Their willingness to participate in the study
  • A score of 24 or higher on the Mini Mental State Test (MMDT)

You may not qualify if:

  • Individuals under the age of 65
  • Individuals who cannot communicate well
  • Elderly individuals who cannot walk independently, have any orthopedic or neurological problems
  • Individuals who do not want to participate in the study
  • Individuals not eligible for bioimpedance analysis (pregnant individuals with pacemakers).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

SarcopeniaSedentary Behavior

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Model Details: There is no randomization in our study, all elderly individuals who meet the inclusion and exclusion criteria will be evaluated.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master of Science Student

Study Record Dates

First Submitted

August 20, 2023

First Posted

August 25, 2023

Study Start

September 1, 2023

Primary Completion

October 1, 2023

Study Completion

January 1, 2024

Last Updated

August 25, 2023

Record last verified: 2023-08